Correction to: Cell Death and Disease (2018)9:1027
published online 09 October 2018
The correct ordering and designations for corresponding/first authors are as follows:
Shanshan Wang1,2*, Mingyue Zhu3, Qiaoyun Wang3, Yuli Hou4, Lei Li5, Honglei Weng6, Yan Zhao4, Dexi Chen1,2, Junli Guo3, Huiguo Ding#5, Mengsen Li#3
1Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China
2Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer, Beijing, China
3Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, China
4Clinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, Beijing, China
5Department of Gastrointestinal and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China
6Molecular Hepatology, University of Heidelberg, University Medical Center Mannheim, 68167 Mannheim, Germany
*First author
# Corresponding author.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, S., Zhu, M., Wang, Q. et al. Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling. Cell Death Dis 10, 83 (2019). https://doi.org/10.1038/s41419-019-1302-1
Published:
DOI: https://doi.org/10.1038/s41419-019-1302-1
